RBC Capital Maintains Sector Perform on Hologic, Lowers Price Target to $72
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has maintained a 'Sector Perform' rating on Hologic (NASDAQ:HOLX) but has reduced the price target from $74 to $72.
November 10, 2023 | 7:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital analyst Conor McNamara maintains a 'Sector Perform' rating on Hologic but lowers the price target from $74 to $72.
The adjustment in price target by RBC Capital is a moderate change, suggesting a slight decrease in expected performance. However, since the rating remains 'Sector Perform', the overall outlook for Hologic has not significantly changed. This may lead to a neutral short-term impact on the stock as the market absorbs the new price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100